Clincosm LogoSign in Get a demo

Cholangiocarcinoma

Showing NaN - NaN of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • +8 more
  • Los Angeles, California
  • +5 more
Nov 29, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Nutritional Preferences and Product Accessibility in Oral

Withdrawn
  • Breast Carcinoma
  • +6 more
  • Interview
  • Survey Administration
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 10, 2020

Cholangiocarcinoma, Hilar Lymphadenopathy, Biliary Stricture Trial in United States (PTBD, ERC)

Terminated
  • Cholangiocarcinoma
  • +2 more
  • PTBD
  • ERC
  • Los Angeles, California
  • +24 more
Mar 23, 2020

Carcinoma of Intrahepatic and Extra-hepatic Biliary System, Carcinoma of Gallbladder, Bile Duct Cancer Trial in United States

Completed
  • Carcinoma of Intrahepatic and Extra-hepatic Biliary System
  • +3 more
  • Los Angeles, California
  • +8 more
Sep 6, 2018

Colorectal Adenocarcinoma, Cholangiocarcinoma, Pancreatic Adenocarcinoma Trial in United States (ceritinib)

Terminated
  • Colorectal Adenocarcinoma
  • +5 more
  • Los Angeles, California
  • +5 more
Mar 29, 2018